HIGHLIGHTS
- who: Yi Zhu from the Department of Cardiology, The Affiliated Changzhou Second Peopleu2019s Hospital of Nanjing Medical University, Changzhou, Peopleu2019s Republic of China have published the research work: Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention, in the Journal: (JOURNAL)
- what: This study was conducted to evaluate the association between administration and adverse events in patients with undergoing percutaneous coronary intervention (PCI).
- how: The results showed that DAPA administration was associated with reduced MACE in patients with AMI particularly in patients with advanced age and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.